Genetics and epigenetics in primary Sjogren's syndrome

被引:72
作者
Imgenberg-Kreuz, Juliana [1 ]
Rasmussen, Astrid [2 ]
Sivils, Kathy [2 ]
Nordmark, Gunnel [1 ]
机构
[1] Uppsala Univ, Dept Med Sci, Rheumatol & Sci Life Lab, S-75185 Uppsala, Sweden
[2] Oklahoma Med Res Fdn, Div Genom & Data Sci, Arthrit & Clin Immunol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA
基金
瑞典研究理事会; 美国国家卫生研究院;
关键词
primary Sjogren's syndrome; genetics; GWAS; HLA; IRF5; STAT4; epigenetics; DNA methylation; histone modification; non-coding RNA; SYSTEMIC-LUPUS-ERYTHEMATOSUS; SALIVARY-GLAND INFLAMMATION; DNA METHYLATION PATTERNS; GENOME-WIDE ASSOCIATION; HLA CLASS-II; AUTOANTIBODY PRODUCTION; SUSCEPTIBILITY LOCUS; MICRORNA EXPRESSION; MONONUCLEAR-CELLS; HAN CHINESE;
D O I
10.1093/rheumatology/key330
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Primary Sjogren's syndrome (pSS) is considered to be a multifactorial disease, where underlying genetic predisposition, epigenetic mechanisms and environmental factors contribute to disease development. In the last 5 years, the first genome-wide association studies in pSS have been completed. The strongest signal of association lies within the HLA genes, whereas the non-HLA genes IRF5 and STAT4 show consistent associations in multiple ethnicities but with a smaller effect size. The majority of the genetic risk variants are found at intergenic regions and their functional impact has in most cases not been elucidated. Epigenetic mechanisms such as DNA methylation, histone modifications and non-coding RNAs play a role in the pathogenesis of pSS by their modulating effects on gene expression and may constitute a dynamic link between the genome and phenotypic manifestations. This article reviews the hitherto published genetic studies and our current understanding of epigenetic mechanisms in pSS.
引用
收藏
页码:2085 / 2098
页数:14
相关论文
共 50 条
[41]   Contribution of Genetic Factors to Sjogren's Syndrome and Sjogren's Syndrome Related Lymphomagenesis [J].
Nezos, Adrianos ;
Mavragani, Clio P. .
JOURNAL OF IMMUNOLOGY RESEARCH, 2015, 2015
[42]   Unified Airway Disease: Genetics and Epigenetics [J].
Brar, Tripti ;
Marino, Michael J. ;
Lal, Devyani .
OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2023, 56 (01) :23-38
[43]   Epigenetics in autoimmune disorders: Highlights of the 10th Sjogren's Syndrome Symposium [J].
Lu, Qianjin ;
Renaudineau, Yves ;
Cha, Seunghee ;
Ilei, Gabor ;
Brooks, Wesley H. ;
Selmi, Carlo ;
Tzioufas, Athanasios ;
Pers, Jacques-Olivier ;
Bombardieri, Stefano ;
Gershwin, M. Eric ;
Gay, Steffen ;
Youinou, Pierre .
AUTOIMMUNITY REVIEWS, 2010, 9 (09) :627-630
[44]   Estimating Indirect Costs in Primary Sjogren's Syndrome [J].
Bowman, Simon J. ;
Pierre, Yvan St. ;
Sutcliffe, Nurhan ;
Isenberg, David A. ;
Goldblatt, Fiona ;
Price, Elizabeth ;
Hamburger, John ;
Richards, Andrea ;
Rauz, Saaeha ;
Regan, Marian ;
Rigby, Shirley ;
Jones, Adrian ;
Mulherin, Diarmuid ;
Clarke, Ann E. .
JOURNAL OF RHEUMATOLOGY, 2010, 37 (05) :1010-1015
[45]   Genetics and epigenetics in the obesity phenotyping scenario [J].
Trang, Khanh ;
Grant, Struan F. A. .
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2023, 24 (05) :775-793
[46]   Genetics in Sjogren's syndrome: where we are and where we go [J].
Harris, V. M. ;
Scofield, R. H. ;
Sivils, K. L. .
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (03) :S234-S239
[47]   Genetics and Epigenetics Mechanism in the Pathogenesis of Behcet's Disease [J].
Muhammad, Jibran Sualeh ;
Ishaq, Muhammad ;
Ahmed, Khalid .
CURRENT RHEUMATOLOGY REVIEWS, 2019, 15 (01) :7-13
[48]   Methotrexate in primary Sjogren's syndrome [J].
Skopouli, FN ;
Jagiello, P ;
Tsifetaki, N ;
Moutsopoulos, HM .
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1996, 14 (05) :555-558
[49]   Targeting primary Sjogren's syndrome [J].
Odani, Toshio ;
Chiorini, John A. .
MODERN RHEUMATOLOGY, 2019, 29 (01) :70-86
[50]   Imaging in Primary Sjogren's Syndrome [J].
van Ginkel, Martha S. ;
Glaudemans, Andor W. J. M. ;
van der Vegt, Bert ;
Mossel, Esther ;
Kroese, Frans G. M. ;
Bootsma, Hendrika ;
Vissink, Arjan .
JOURNAL OF CLINICAL MEDICINE, 2020, 9 (08) :1-21